Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Dr. Reddy’s Makes Strategic Move Into Turkey Through Biosimilars

This article was originally published in PharmAsia News

Executive Summary

Dr. Reddy’s, one of India’s leading pharmaceutical companies, has entered into a strategic alliance with TR-Pharm to enter the Turkish market, in a deal that includes three biosimilars from the Indian firm and is part of its ongoing push into global emerging markets.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register